Soter Technologies’ team of engineers and medical advisors have been working around the clock since December 2019 to create, design and build technology to help reduce the spread of the COVID-19 pandemic, other illnesses and to aid with the re-opening of the economy. The company is known for the international headlines it has generated as inventors of a K-12 school vape detection sensor and alert system, FlySense.
Soter Technologies has announced that the SymptomSense Medical Evaluation Gateway, a non-invasive walk-through electronic full-body symptom scanner for providing detection of symptoms of known illness in less than 10 seconds, has moved into the production phase.
SymptomSense is an electronic walk-through full-body symptom scanner that looks similar to metal detectors used at security checkpoints of airports, sporting events and government buildings. Similar to the evaluation that an individual would receive at a hospital emergency room SymptomSense gathers critical vitals including blood oxygen level, which is more important than body temperature, when assessing if an individual is ill.
SymptomSense uses an array of sensors to provide a non-invasive, hands-free approach for gaining real-time vital signs, including detecting blood oxygen levels, external body temperature within 0.2 degrees of accuracy (Celsius), elevated heart rate, respiration rate, shortness of breath, lung congestion, height, weight and, in the future, non-contact blood pressure. Within seconds the SymptomSense device provides health status with messaging and indicators for screening staff, and, in the future, data mapping of alerts to an electronic system-of-records that can be shared with authorities as may be required per local laws and ordinances.
The development and beta testing of prototypes started in late 2019 in response to the COVID-19 outbreak in China. Fortune 100 companies; major league professional sports teams; entertainment parks; Broadway theater management companies; real estate development and management companies; U.S. federal government departments and governments around the globe have all expressed interest and are reviewing SymptomSense for potential use.
SymptomSense allows on-site security personnel to screen and use the Soter’s AI (Artificial Intelligence) technology to identify individuals with known symptoms prior to entry into hospitals, schools, airports, train stations, government buildings, military bases, stadiums, malls, and other such facilities that must remain open. Soter has accepted orders from clients in the U.S., Europe and countries around the world with delivery of the first units set for June 2020. The company formed an Advisory Board of doctors, scientists and engineers that continues to work with the medical and research community to enhance its technology and capabilities. For example, SymptomSense includes a module for weapons detection to provide property managers with an all-in-one access reassurance solution.
SymptomSense can scan approximately 1,500 people per hour and is capable of processing over 10,000 people over an 8-hour period, with zero downtime. For airline and other transportation systems, an optional built-in facial recognition technology is available for data-mapping to government registry. In doing so, SymptomSense platform enables building / site security personnel to track the movement of potential carriers of a virus, while protecting their privacy. This data capture and mapping capability is important for understanding current and predictive patterns, trending for the spread of disease, and to help trace back to most-current disease geo-location clustering and origin. As needed, the platform can be linked to mobile phone contact tracing data, local weather data, and demographic data as may be required by government agencies.